January 22, 2024

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

The NRG Oncology 2024 Winter Meeting is Open for Registration!

The NRG Winter Meeting will be held in-person only at the World Center Marriott in Orlando, FL from Thursday, February 15, 2024 - Saturday, February 17, 2024 with select virtual session offerings. Please visit our meeting webpage for the agenda and more information. Register here

The Role of Spatial Biology in Oncology at #NRG2024

The NRG Translational Science Committee will be hosting their session “The Role of Spatial Biology in Oncology: Opportunities and Challenges for Translational Research” on Thursday, February 15, 2024 from 3-5pm at the upcoming NRG Meeting in Orlando. Presentations include the 3D spatial biology of archived FFPE tissue, new insights and opportunities in spatial biology, the multiplexed tissue imaging for biomarker and translational science discovery, and whole slide imaging mass cytometry for rapid profiling of tumor spatial heterogeneity and immune microenvironments. View the session flyer here. Register here. Click here to view the session flyer.

Winter Symposium - IDEA: Inclusion, Diversity, Equity and Access of Underrepresented Patients to Clinical Trials

Register here for the Winter 2024 Educational Symposium on Thursday, February 15, 2024 from 8am-12pm ET. The symposium will include noted Oncologists and Scientists serving as speakers and moderators. The speakers will focus their presentations on providing a framework for the barriers and solutions to increasing IDEA (Inclusion, Diversity, Equity, and Access) of underrepresented patients to clinical trials. Read more

NRG Oncology Protocol Support Committee – Educational Sessions

Please be sure to sign up to attend the PSC Nurse/CRP Sessions being held during the NRG Oncology Winter Meeting in Orlando. The Protocol Support Committee (PSC) will offer Introduction to Clinical Trials: Principles of NRG Oncology Clinical Trial Management for Nurse/CRPs on Thursday, February 15th; and Continuing Education Session for Nurse/CRPs on Friday, February 16th. These sessions will be held virtually and in-person and are for both seasoned and new research staff. Please refer to the posted flyers and agendas (login required) for more details about the PSC programing offered at #NRG2024.

The PSC is thrilled to announce that the PSC sessions have been approved by the Virginia Nurses Association to award contact hours. The Virginia Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

#NRG2024 Social Media Workshop – Virtual Session

The NRG Oncology Communications Committee is pleased to announce our Social Media Workshop as part of #NRG2024. The workshop, held as a virtual session, is scheduled for Monday, February 12th from 4-5pm ET. Drs. Kristin Higgins and Miriam Knoll, members of the NRG Oncology Communications Committee, are the workshop chairs. The session speakers include Kristen Kimball, advocate for lung cancer awareness and retired physiology instructor from Boston; and Dr. Lucinda Morris, a radiation oncologist and co-chair of the Targeting Cancer initiative, from Sydney, Australia. Please see the session flyer for details. Register here.

ACTIVATION

GYNECOLOGIC

NRG-GY033: Activation Date: January 22, 2024 (posted on CTSU)

REACTIVATION/AMENDMENT

GYNECOLOGIC

NRG-GY027: Reactivation and Amendment 3; version date: December 22, 2023. Now open to accrual in the expansion phase (documents posted on CTSU and NRG Oncology)

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANK

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. CANCER CONTROL & PREVENTION

NRG-CC010: The study is now open to NRG sites in Japan and South Korea. The optional biospecimen collection does not apply to sites participating in these countries.

4. GENITOURINARY

NRG-GU010: Updated Training slides, overview slides, and drug destruction form are posted on CTSU.

NRG-GU012: Reminder! This phase II trial for patients with metastatic unresected renal cell cancer is open to enrollment. The study is open to all NCTN member sites in the U.S and Canada. Please help us enroll. Protocol documents are posted on CTSU.

5. GYNECOLOGIC

EAY191-N4: Appendix XI, Section II, 1^st bullet: Reports should be REDACTED. Section 10.2: Footnote 2 will be deleted. These changes will be made with the next amendment.

GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

6. HEAD & NECK

NRG-HN008: Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

7. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, NRG-BR009 and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, February 21, 2024.

NRG Biobank Pittsburgh Relocation

Please note that the NRG Oncology Biobank Pittsburgh will relocate at the end of January 2024. As of February 1, 2024, the new address will be:

Nova Place

100 South Commons, Suite 120

Pittsburgh, PA 15212

Please refrain from shipping blocks and slides designated to be submitted to the Pittsburgh Biobank from January 22-31. The biobank’s phone number will not change. Please call or e-mail with any questions at 412-697-6611 or NRGbiobankPGH@nrgoncology.org.

Reminder! New Request for Early IRB Closure Form

CTSU’s Request for LPO Approval of Early Closure Form is now available on the CTSU website under Resources > CTSU Operations Information > CTSU Forms. This form will replace the NRG Early IRB Closure form. Additional NRG instructions are located on the NRG website. When a site wants to close a study locally prior to study-wide termination, they must complete and submit this form to NRG. If approved, they must then submit it to the NCICIRB via IRBManager or to the CTSU via the Regulatory Submission Portal, whichever is appropriate per the instructions. The CIRB and the CTSU will not process an early closure without documentation that the LPO has approved it. 

NRG Oncology Confidential Member Survey

Please read our survey FAQ’s. All NRG Members should have received an email from the University of Chicago’s Survey Lab containing a unique survey link. If you have not already completed the survey, please check your inbox and possibly your spam/junk mailbox for the email so that you can help us collect this important information. Please send any additional questions to nrg-broadcasts@nrgoncology.org.

REMINDER: Any manuscript or abstract resulting from research done under the auspices of our NCI grant awards must be processed through the NRG Publications Office before being submitted to the journal or association. Please remember to cite any pertinent grant numbers in these publications.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS

American Association for Cancer Research (AACR); Apr 5-10, 2024; San Diego, CA

American Association for Thoracic Surgery (AATS); Apr 27-30, 2024; Toronto, ON

American College of Radiology (ACR); Apr 13-17, 2024; Washington, DC

American Head & Neck Society (AHNS); May 15-16, 2024; Chicago, IL

American Radium Society (ARS); May 2-5, 2024; Palm Springs, CA

American Society of Breast Surgeons (ABS); Apr 10-14, 2024; Orlando, FL

American Society of Clinical Oncology (ASCO) GU; Jan 25-27, 2024; San Francisco, CA

Society for Clinical Trials (SCT); May 19-22, 2024; Boston, MA

Society of Gynecologic Oncology (SGO); Mar 16-18, 2024; San Diego, CA

Society of Surgical Oncology (SSO); Mar 20-23, 2024; Atlanta, GA

Society of Surgical Oncology (SSO) - Advanced Cancer Therapies (ACT); Feb 16-19, 2024; San Juan, Puerto Rico

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Brachytherapy Society (ABS) World Congress; Jul 10-13, 2024; National Harbor, MD; due to publications committee Feb 13, 2024; submission deadline Feb 27, 2024, 6:00 pm PT

American Society of Clinical Oncology (ASCO); May 31-Jun 4, 2024; Chicago, IL; due to publications committee Jan 23, 2024; submission deadline Feb 6, 2024, 11:59 pm ET; LBA Mar 11, 2024, 11:59 pm ET (placeholder required)

American Society of Colon and Rectal Surgeons (ASCRS); Jun 1-4, 2024; Baltimore, MD; submission deadline Feb 13, 2024, 11:59 pm PT

American Society for Radiation Oncology (ASTRO); Sep 29-Oct 2, 2024; Washington, DC; due to publications committee Feb 27, 2024; submission deadline Mar 12, 2024; LBA Jul 12, 2024

EORTC-NCI-AACR Symposium on Molecular Targets and therapies; Oct 23-25, 2024; Barcelona, Spain; due to publications committee Jun 13, 2024; submission deadline Jun 27, 2024; LBA Sep 26, 2024

European Society of Gynaecological Oncology (ESGO); Mar 7-10, 2024; Barcelona, Spain; LBA Jan 15, 2024

European Society for Medical Oncology (ESMO); Sep 13-17, 2024; Barcelona, Spain; due to publications committee Apr 23, 2024; submission deadline May 7, 2024, 21:00 CET; LBA Aug 7, 2024, 21:00 CET (placeholder required)

European Society for Medical Oncology (ESMO) Breast Cancer; May 15-17, 2024; Berlin, Germany; due to publications committee Jan 30, 2024; submission deadline Feb 13, 2024, 21:00 CET; LBA Apr 17, 2024, 21:00 CET (placeholder required)

European Society for Medical Oncology (ESMO) Gastrointestinal; Jun 26-29, 2024; Munich, Germany; due to publications committee Jan 30, 2024; submission deadline Apr 9, 2024, 21:00 CET; LBA Jun 6, 2024, 21:00 CET (placeholder required)

European Society for Medical Oncology (ESMO) Gynaecological; Jun 20-22, 2024; Florence, Italy; due to publications committee Mar 20, 2024; submission deadline Apr 3, 2024, 21:00 CET (placeholder required)

European Society for Radiotherapy and Oncology (ESTRO); May 3-7, 2024; Glasgow, Scotland; LBA Jan 24, 2024